Infertility Clinical Trial
Official title:
A Controlled Randomized Trial Evaluating the Effect of Lowered Incubator Oxygen Tension on Live Births in a Predominantly Blastocyst Transfer Program
The potentially damaging effect of free O2 radicals to cultured embryos may be reduced by adding scavengers to the culture media or by reducing the incubator O2 levels. However, lowering the O2 in the culture environment can be expensive, troublesome and may not be justifiable. The objective of this study is to evaluate the effect of lowered incubator O2 tension on live birth rates in a predominately day-5 embryo transfer program. The hypothesis of this study is that a lowered (more physiological)oxygen concentration in embryo culture incubators will increase live birth rates for in vitro fertilization patients. 230 first-cycle women undergoing routine IVF or ICSI with ejaculated sperm will be randomized in a prospective clinical trial and stratified for patient age and physician. Embryos of patients will be randomly assigned for culture in either a 21% O2 (atmospheric) or 5% O2 (reduced) environment. Clinical endpoints monitored will be rates of implantation, clinical pregnancy, live birth and blastocyst cryopreservation.
Purpose: The purpose of this study is to determine if a more physiological oxygen
concentration (5%) will improve clinical outcomes when compared with the industry standard
of 21%.
Background: For embryos to grow in the incubator, atmospheric gas concentrations should be
as close to possible to those seen in the oviduct or uterus. Currently, atmospheric
(non-physiological, 21%) oxygen concentrations are used in the incubators to culture the
embryos of infertility patients of the Presbyterian ARTS laboratories. Literature suggest
that culturing animal embryos in a reduced oxygen environment will significantly improve
embryo quality and clinical outcomes. Both 5% and atmospheric oxygen concentrations are
routinely used for embryo culture in the human IVF laboratories, however, very few
commercial human IVF facilities invest in oxygen control as it is more expensive to maintain
and labor intensive to implement. The goal is to use lower oxygen concentrations in the
future if clinical improvement justifies the expense and increased labor associated with low
oxygen culture.
Project Summary: Study design: The study will be conducted in a prospective, randomized way.
Two treatment groups are considered: 1) existing atmospheric oxygen concentration in embryo
incubators 2) lower 5% oxygen concentration in embryo culture incubators. To allow for the
well-documented decline in pregnancy rates with increased age, patients will be stratified
within 4 age groups and 3 physicians within each treatment. The age groups are: donor eggs;
<35 years; 35 to 37 years; and 38 to 40 years as determined on the day of egg retrieval.
Endpoints Measured: The endpoints measured will be embryo cryopreservation-biochemical
pregnancy-, clinical pregnancy-, ongoing pregnancy-, live birth- and embryo implantation
rates.
Number of Patients in the Study: To detect a difference of 10% in pregnancy rates, 150
patients should be included in each treatment group. With the current patient volume, it
should take less than one year to complete the study. Differences in implantation rates may
be detected earlier (more embryos transferred than patients enrolled). Should significance
differences in pregnancy rates become evident before the full number of patients is
enrolled, the study may be terminated.
Study Location: The study will be conducted at the ARTS facility of Presbyterian Hospital of
Plano.
Criteria for Inclusion of Subjects: All patients undergoing a first IVF cycle or any donor
oocyte cycle is eligible to participate in this laboratory comparison. The eggs may be
fertilized with conventional IVF methodology or by using intracytoplasmic sperm injection
(ICSI). When performing ICSI, ejaculated sperm must be used. Patients using their own eggs
must be 40 years of age or younger on the day of egg retrieval. The Presbyterian Hospital
ARTS Program performed ~900 egg retrievals in 2000. Of these, ~500 would have met the
inclusion criteria of this study.
Criteria for Exclusion of Subjects: To reduce the tremendous patient variability seen in the
infertile patient population, only first cycle patients 40 years of age or younger on the
day of egg retrieval should participate.
Sources of Research Material: Patients will be enrolled in this study from the regular
patient pool presented to the Presbyterian ARTS Program for treatment of infertility. Data
will not be collected specifically for research purposes. Data to be used are collected on
all ARTS patients, regardless of participation in the study.
Recruitment of Subjects: Subjects for this study will be recruited from the regular patient
pool presented to the ARTS Program for the treatment of infertility. Patients that will meet
the inclusion criteria of this study can be identified prospectively. Information about the
study will be included in the routine, biweekly, group laboratory and nursing orientation
sessions.
Potential Risks: Patients consenting to the comparison will allow their embryos to be
cultured in either the standard atmospheric oxygen concentration or in a reduced, more
physiological oxygen concentration. Atmospheric (21%) oxygen concentrations is the current
standard in this program. Both methods are considered industry standard. To our best
knowledge and as reported in animal literature, low oxygen culture should do better rather
than worse under the conditions proposed for this study. No other culture conditions or
culture media compositions/ingredients that will be applied during this comparison is
experimental. However, when atmospheric oxygen concentrations and lowered (5%) oxygen
concentrations are compared in a controlled, randomized way as suggested in this comparison,
the ARTS Program can not guarantee that the pregnancy outcome will be equivalent for both
treatment groups. Therefore, by being randomized, a patient may be included in a group with
a lower success rate.
Special Precautions: If it should become clear early in the study that either one of the
treatments are superior to the other, the study will be discontinued and the best conditions
implemented for future patients.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03607409 -
Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
|
||
Recruiting |
NCT02312076 -
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles
|
Phase 4 | |
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Completed |
NCT03287479 -
Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®)
|
N/A | |
Terminated |
NCT03522350 -
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
|
N/A | |
Completed |
NCT04496284 -
Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen
|
N/A | |
Completed |
NCT03623659 -
pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts
|
N/A | |
Completed |
NCT03895099 -
New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors
|
Phase 3 | |
Active, not recruiting |
NCT04142112 -
Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation
|
N/A | |
Completed |
NCT03152643 -
Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer
|
N/A | |
Recruiting |
NCT03683771 -
Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
|
||
Recruiting |
NCT03161119 -
Comparing Two Different Embryo Transfer Catheters
|
N/A | |
Completed |
NCT04108039 -
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
|
N/A | |
Completed |
NCT03678558 -
Oocyte Vitrification Aided With Cytochalasin B
|
N/A | |
Completed |
NCT03677492 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD)
|
N/A | |
Completed |
NCT03678818 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA)
|
N/A | |
Completed |
NCT03678597 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB)
|
N/A | |
Completed |
NCT03678610 -
Handling Medium for ICSI With Ionomycin and Latrunculin A
|
N/A | |
Completed |
NCT03678584 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA)
|
N/A | |
Completed |
NCT03678571 -
Oocyte Vitrification Aided With Latrunculin A
|
N/A |